Actinium Submits Iomab-B IND Application to the U.S. FDA
NEW YORK, NY--(Marketwired - November 17, 2015) - Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium" or "the Company"), is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment …